fenofibrate has been researched along with i(3)so3-galactosylceramide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, T; Hara, A; Kamijo, Y; Kimura, T; Kyogashima, M; Nakajima, T; Nakamura, K; Sugiyama, E; Tanaka, N; Yuzhe, H | 1 |
| Aoyama, T; Feng, Y; Kamijo, Y; Nakajima, T; Sugiyama, E; Tanaka, N; Yang, Y; Zhang, X | 1 |
| Buschard, K; Claessens, LA; Dahl-Jørgensen, K; Gerling, IC; Hanssen, KF; Hasselby, JP; Holm, LJ; Kaur, S; Koeleman, BPC; Krogvold, L; Mathews, CE; Morgan, NG; Pociot, F; Roep, BO; Russell, MA | 1 |
| Buschard, K | 1 |
4 other study(ies) available for fenofibrate and i(3)so3-galactosylceramide
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor α mediates enhancement of gene expression of cerebroside sulfotransferase in several murine organs.
Topics: Animals; Brain; Fenofibrate; Intestinal Mucosa; Kidney; Liver; Mice; Mice, Knockout; Myocardium; Organ Specificity; PPAR alpha; RNA, Messenger; Sulfoglycosphingolipids; Sulfotransferases; Transcription, Genetic | 2013 |
Activation of PPARα by Fatty Acid Accumulation Enhances Fatty Acid Degradation and Sulfatide Synthesis.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; DNA; Fatty Acids; Fenofibrate; Gene Expression Regulation; Humans; Indoles; Metabolic Networks and Pathways; PPAR alpha; Protein Binding; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sulfoglycosphingolipids; Triglycerides | 2016 |
Abnormal islet sphingolipid metabolism in type 1 diabetes.
Topics: Adult; Animals; Autoimmunity; Case-Control Studies; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Fenofibrate; Gene Expression Regulation, Enzymologic; Humans; Islets of Langerhans; Lipid Metabolism; Lymphocyte Activation; Male; Mice, Inbred NOD; Polymorphism, Genetic; Sulfoglycosphingolipids; T-Lymphocytes | 2018 |
Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19.
Topics: Adult; Aging; Betacoronavirus; Child; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Fenofibrate; Humans; Hypercholesterolemia; Hypertension; Hypolipidemic Agents; Pandemics; Pneumonia, Viral; PPAR alpha; SARS-CoV-2; Sulfoglycosphingolipids; Virus Internalization | 2020 |